A5068060598- Amyloidosis: Diagnosis, Treatment, Outcomes
- Parathyroid Disorders and Treatments
- Frailty in Older Adults
- Nutrition and Health in Aging
- GDF15 and Related Biomarkers
- SARS-CoV-2 and COVID-19 Research
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Bone health and treatments
- Hemoglobinopathies and Related Disorders
- Thyroid Disorders and Treatments
- Venous Thromboembolism Diagnosis and Management
- COVID-19 Clinical Research Studies
- Viral Infections and Immunology Research
- Acute Myocardial Infarction Research
- Inflammatory Biomarkers in Disease Prognosis
Chinese Academy of Medical Sciences & Peking Union Medical College
2023-2025
Fu Wai Hospital
2024
Abstract Aims Red blood cell distribution width‐to‐albumin ratio (RAR), an innovate biomarker of inflammation, can independently predict adverse cardiovascular outcomes. However, the association between RAR and prognosis in patients with non‐ischaemic heart failure (NIHF) remains unclear. Methods results A total 2077 NIHF admitted to Heart Failure Care Unit, Fuwai Hospital, were consecutively enrolled from December 2006 October 2017 this retrospective study. The primary endpoint was a...
Research on iron deficiency (ID) in patients with light chain cardiac amyloidosis (AL-CM) has been limited previous studies. The purpose of this study was to investigate the prevalence and its association prognosis ID based different definitions AL-CM. Three were applied: (1) serum ferritin concentration <100 ng/mL, or 100-299 ng/mL transferrin saturation (TSAT) < 20% (according guidelines heart failure), (2) TSAT (3) <13 μmol/L. primary outcome measure all-cause mortality. Prevalence...
Abstract Background Thyroid dysfunction might have a negative impact on the prognosis of patients with heart failure (HF) and affect lipid metabolism. The aim our study was to investigate prognostic role thyroid its relationship profile in hospitalized HF patients. Hypothesis strongly correlates combination improves value. Methods We performed single‐center retrospective cohort including between March 2009 June 2018. Results Among enrolled 3733 patients, low fT3 (hazard ratio [HR] 1.33; 95%...
Abstract Aims Acute myocarditis (AM) has been recognized as a rare complication of coronavirus disease 2019 (COVID‐19) infection. This study was conducted to present the clinical characteristics, courses and short‐term prognoses Omicron variant severe acute respiratory syndrome 2 (SARS‐CoV‐2) induced AM in China, which unavailable so far. Methods results Data from 28 patients diagnosed with definite COVID‐19–associated 6 hospitals China between 1 December 2022 30 June 2023 were collected...
Background: Previous research on the iron deficiency (ID) of patients with light chain cardiac amyloidosis (AL-CA) has been limited. Aims: The purpose this study was to investigate how different definitions ID affect its prevalence and association prognosis in AL-CA. Methods: Consecutive diagnosed AL-CA at Heart failure Center, Fuwai hospital between September 2017 July 2023 available status were included. defined as (1) serum ferritin concentration <100 ng/ml, or 100-299 ng/ml...
Background: The predictive value of soluble suppression tumorigenicity-2 (sST2) has been demonstrated in heart failure patients. However, studies on the association between baseline sST2 levels, dynamic changes sST2, and prognosis patients with light chain cardiac amyloidosis (AL-CA) are limited. Aim: study sought to assess circulating added prognostic change levels AL-CA. Methods: Patients diagnosed AL-CA Heart Failure Center, Fuwai Hospital October 2015 August 2023 were enrolled. serum...